Vasectomy — Procedure Guide, Recovery & Risks | MyMedicPlus

Vasectomy is a minor surgical procedure for permanent male contraception that achieves sterilisation by interrupting the bilateral vas deferens — the paired muscular tubes that carry sperm from the epididymis to the ejaculatory duct and seminal vesicles for inclusion in ejaculate — preventing sperm from reaching semen without affecting semen volume (which comes primarily from the seminal vesicles and prostate), sexual function, libido, or testosterone production. The procedure achieves its contraceptive effect within 8-16 weeks (or approximately 20 ejaculations) after surgery, when all residual sperm have cleared the reproductive tract distal to the occlusion; a confirmatory post-vasectomy semen analysis (PVSA) at 12-16 weeks is mandatory to confirm azoospermia before contraception is discontinued. Vasectomy is among the most effective contraceptive methods available, with a 10-year cumulative failure rate of 0.1-0.15% — superior to all female contraceptive methods except the levonorgestrel-releasing IUS — and is substantially simpler, safer, less invasive, and cheaper than female sterilisation (bilateral salpingectomy), which requires general anaesthesia and abdominal entry. Modern vasectomy techniques include the conventional incisional approach (one or two small scrotal incisions) and the no-scalpel vasectomy (NSV), which uses a sharp-pointed haemostat clamp to puncture the scrotal skin over the vas through a single tiny puncture wound rather than a formal incision, dramatically reducing bleeding, wound complications, post-operative discomfort, and procedure time.

Vasectomy is chosen by men and their partners who have completed their family or who have made a definitive decision not to have biological children, and who seek reliable, permanent contraception without ongoing requirements. It is appropriate for men of any age who meet these criteria after informed counselling, though most practitioners will counsel younger men without children more extensively given the possibility of changing circumstances. Vasectomy is safer, cheaper, and more effective than female surgical sterilisation (tubal ligation), does not require general anaesthesia, and avoids the intra-abdominal operative risks of laparoscopic female sterilisation. It does not affect testosterone levels, sexual drive, erection quality, or orgasm. Men should be counselled that vasectomy is intended to be permanent — reversal is possible but success rates decline significantly with time and reversal is not always funded — and that alternative contraception must continue until azoospermia is confirmed on post-vasectomy semen analysis at 12 weeks or after 20 ejaculations.

Vasectomy is performed as an outpatient procedure under local anaesthesia without sedation, in a minor procedures room, urology clinic, or family planning clinic. The patient lies supine, and the vas deferens is located within the scrotal contents by palpation. The vas is secured and brought close to the skin surface using a 3-finger technique with the surgeon's non-dominant hand. Local anaesthetic — typically 1–2 mL of 1% or 2% lidocaine — is injected using a fine needle through the scrotal skin above the vas, providing complete anaesthesia within 3–5 minutes. Using the no-scalpel technique, a sharpened curved haemostat penetrates the skin and opens the scrotal wall with a spreading motion, delivering the vas into the operative field without an incision. The fascial sheath of the vas is opened and the vas freed from surrounding structures. A 1–2 cm segment of the vas is excised and the cut ends treated: the testicular (proximal) end is cauterised with electrofulguration and clipped, while the prostatic (distal) end is similarly sealed. Fascial interposition separates the two ends in different tissue planes to minimise spontaneous reconnection. The procedure is repeated on the contralateral side through the same skin puncture (single-puncture technique) or a second small puncture. Total operating time is 15–30 minutes. The skin puncture requires no suture and heals within 2–3 days.

After confirmed azoospermia on post-procedure semen analysis, vasectomy provides greater than 99.9% contraceptive efficacy — more effective than any female reversible contraceptive method, female surgical sterilisation, hormonal contraceptives, or barrier methods. The procedure eliminates the daily burden of contraceptive compliance that falls predominantly on women in most couples, providing effective contraception throughout the remaining reproductive years without further intervention. Vasectomy has no systemic hormonal effects, does not affect cardiovascular health, sexual function, testosterone, or long-term prostate cancer risk (decades of follow-up data have definitively refuted earlier concerns). It is substantially less invasive, less expensive, and associated with lower surgical risk than tubal ligation. Satisfaction rates in men who have undergone vasectomy are consistently high in follow-up studies, exceeding 90% when appropriate pre-operative counselling was provided and the decision was made without partner pressure.

Post-vasectomy pain syndrome — chronic scrotal ache or discomfort persisting for more than 3 months after surgery — occurs in approximately 1–2% of men and may be difficult to treat; most cases resolve with conservative management including scrotal support and anti-inflammatory medication, but a small proportion require epididymectomy or reversal. Haematoma (blood collection in the scrotum) is the most common early complication, occurring in 2–4% with the no-scalpel technique, though large haematomas are rare and require surgical drainage in fewer than 0.5% of cases. Sperm granuloma — a tender inflammatory nodule at the vasectomy site from leaked sperm — occurs in 2–3% and usually resolves spontaneously or with anti-inflammatory treatment. Wound infection is uncommon (under 1%). Spontaneous recanalization (late failure) occurs in approximately 1 in 2,000 vasectomies performed with modern combined technique — the main reason azoospermia confirmation on post-vasectomy semen analysis is mandatory before stopping other contraception. There is no evidence of increased risk of prostate cancer, testicular cancer, or cardiovascular disease following vasectomy from long-term epidemiological data.

Following vasectomy, scrotal support underwear and intermittent ice packs applied for 20 minutes every 2 hours for the first 24–48 hours minimise swelling and discomfort. Paracetamol and ibuprofen manage post-procedure pain, which is typically mild to moderate in the first 1–3 days. The skin puncture site heals within 2–3 days; no suture removal is required. Sedentary work may resume after 2–3 days; strenuous physical work, exercise, and sexual activity should be avoided for 5–7 days. Alternative contraception must be continued without exception until azoospermia is confirmed — this takes 12 weeks or 20 ejaculations, whichever comes later, as residual sperm remain in the reproductive tract beyond the vasectomy site. A semen sample is produced at home and delivered to the laboratory at the scheduled time. Azoospermia (zero sperm on the semen analysis) confirms successful vasectomy and allows contraception to be discontinued. If a small number of non-motile sperm are found, repeat testing at a further 4–6 weeks may still confirm success depending on local laboratory interpretation guidelines.